Back to BlackRock, Inc. BlackRock, Inc.

KNSAKNSA
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in KINIKSA PHARMACEUTICALS INTL

BlackRock, Inc. holds 2.7M shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $175.2M as of 2026-Q2. The position was increased (+462.9% shares). KNSA represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$175.2M

Current Shares

2.7M

Total Value Change

+$104.5M

Total Shares Change

-832,248

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.7M
+462.9%
$175.2M0.0%$63.95
49
2026-Q1
Increased
486,737
+9.0%
$23.4M0.0%$45.37
31
2025-Q4
Decreased
446,603
-2.4%
$18.4M0.0%$40.99
0
2025-Q3
Decreased
457,647
-34.9%
$17.8M0.0%$38.77
0
2025-Q2
Decreased
702,880
-79.5%
$19.4M0.0%$28.04
0
2025-Q1
Decreased
3.4M
-3.9%
$76.2M0.0%$23.09
0
2024-Q4
New
3.6M
-
$70.7M0.0%$19.60
41

Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used